Skip to main content

Table 1 Subtype specificity of RB1 LOH and RB1 and p16INK4a immunohistochemistry

From: The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas

 

Basal-like

HER2-enriched

Luminal A

Luminal B

Normal-like

Total

 

RB1 LOH

       

LOH positive

13 (48.2)

3 (11.1)

3 (11.1)

8 (29.6)

0 (0)

27

 

LOH negative

5 (12.5)

6 (15.0)

17 (42.5)

5 (12.5)

7 (17.5)

40

 

Total

18

9

20

13

7

67

p = 2.26E-04

RB IHC

       

0

6 (42.9)

2 (14.3)

3 (21.4)

3 (21.4)

0 (0)

14

 

1+

13 (29.6)

5 (11.4)

14 (31.8)

4 (9.1)

8 (18.2)

44

 

2+

5 (12.8)

6 (15.4)

14 (35.9)

6 (15.4)

8 (20.5)

39

 

3+

7 (35.0)

2 (10.0)

4 (20.0)

7 (35.0)

0 (0)

20

 

Total

31

15

35

20

16

117

p = 0.0644

p16 IHC

       

0

2 (8.0)

4 (16.0)

8 (32.0)

6 (24.0)

5 (20.0)

25

 

1+

5 (15.2)

3 (9.1)

15 (45.5)

5 (15.2)

5 (15.2)

33

 

2+

4 (13.8)

4 (13.8)

9 (31.0)

6 (20.7)

6 (20.7)

29

 

3+

22 (68.8)

4 (12.5)

3 (9.4)

3 (9.4)

0 (0)

32

 

Total

33

15

35

20

16

119

p = 1.41E-05

  1. 0 = negative, 1+ = weak positive, 2+ = moderate positive, 3+ = strong positive. P-values determined by Fisher's exact test.
  2. HER2 = human epidermal growth factor receptor 2; IHC = immunohistochemistry; LOH = loss of heterozygosity; RB1 = retinoblastoma.